A hyaluronan synthase suppressor, 4-methylumbelliferone, inhibits liver metastasis of melanoma cells (Q34414905)

2 August 2017

A hyaluronan synthase suppressor, 4-methylumbelliferone, inhibits liver metastasis of melanoma cells (English)

1 reference

2 August 2017

1 reference

Shuichi Yoshihara

1

1 reference

2 August 2017

Atsushi Kon

2

1 reference

2 August 2017

Daisuke Kudo

3

1 reference

2 August 2017

Hideaki Nakazawa

4

1 reference

2 August 2017

Ikuko Kakizaki

5

1 reference

2 August 2017

Mutsuo Sasaki

6

1 reference

2 August 2017

Masahiko Endo

7

1 reference

2 August 2017

Keiichi Takagaki

8

1 reference

2 August 2017

language of work or name

English

0 references

publication date

9 April 2005

1 reference

2 August 2017

1 reference

2 August 2017

579

1 reference

2 August 2017

12

1 reference

2 August 2017

2722-2726

1 reference

Biological diversity in metastatic neoplasms: origins and implications.

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.03.079

Clinical targets for anti-metastasis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.03.079

Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone marrow endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.03.079

Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.03.079

Glyco- and immunohistochemical refinement of the differential diagnosis between mesothelioma and metastatic carcinoma and survival analysis of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.03.079

Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.03.079

Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.03.079

Inhibition of hyaluronan synthesis in Streptococcus equi FM100 by 4-methylumbelliferone

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.03.079

A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.03.079

Effect of a hyaluronan synthase suppressor, 4-methylumbelliferone, on B16F-10 melanoma cell adhesion and locomotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.03.079

Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.03.079

Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.03.079

Increased synthesis of hyaluronate enhances motility of human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.03.079

10.1016/J.FEBSLET.2005.03.079

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference